Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03990454
Title Safety Study of SLC-391 in Subjects With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors SignalChem Lifesciences Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.